FDA Drug Recalls

Recalls / Class II

Class IID-0675-2025

Product

Carbamazepine Extended-Release Tablets, USP 400 mg, 30 Tablets per carton (3x10 unit dose cards), Rx Only, American Health Packaging, Columbus, OH 43217. Carton NDC 60687-594-21; (Individual Dose NDC: 60687-594-11)

Brand name
Carbamazepine
Generic name
Carbamazepine
Active ingredient
Carbamazepine
Route
Oral
NDCs
60687-583, 60687-594
FDA application
ANDA211623
Affected lot / code info
Lot #: 1024078, Exp. Date 08/31/2026

Why it was recalled

Failed Dissolution Specifications.

Recalling firm

Firm
Amerisource Health Services LLC
Manufacturer
American Health Packaging
Notification channel
Letter
Type
Voluntary: Firm initiated
Address
2550 John Glenn Ave Ste A, N/A, Columbus, Ohio 43217-1188

Distribution

Quantity
360 cartons
Distribution pattern
Nationwide in the USA.

Timeline

Recall initiated
2025-09-15
FDA classified
2025-09-29
Posted by FDA
2025-10-08
Status
Ongoing

Source: openFDA Drug Enforcement endpoint. Recall record D-0675-2025. The FDA issues recall classifications as health-hazard assessments, not legal findings; for legal claims consult a licensed attorney.